Huntington's disease is the most common neurodegenerative disorder controlled by a single gene and is characterized by motor and cognitive deficits and psychiatric symptoms. Currently, no treatments can stop or reverse the ...
Oct 13, 2023
0
73
Hispanic Heritage Month pays tribute to the history, culture and traditions of Americans of Hispanic ancestry.
Oct 11, 2023
0
20
People with early Alzheimer's disease have difficulty turning when walking, according to a new study using virtual reality led by UCL researchers.
Oct 11, 2023
0
23
Researchers have now combined STED microscopy, a technology that allows superresolution visualization, and a recently created new antibody to observe the amyloidogenic aggregates characteristic of Alzheimer's disease. The ...
Oct 11, 2023
0
17
A new study published in JMIR Aging identifies the major challenges and needs of the 11 million Americans who act as caretakers for family members with dementia.
Oct 10, 2023
0
1
Exactly how Alzheimer's disease develops is not well understood, but an imbalance of iron in the brain might just play a role. Martina Huber of the Leiden Institute of Physics studied iron storage in the brain and managed ...
Oct 10, 2023
0
21
A research team led by the Keck School of Medicine of USC has discovered that a non-invasive eye exam may be a possible tool for screening Black Americans and other people from underdiagnosed and high-risk populations for ...
Oct 6, 2023
0
40
Dementia, which includes Alzheimer's disease, currently affects around 1.8 million people in Germany. The exact cause has not yet been clarified, but genetic factors play a significant role in the development of the disease. ...
Oct 6, 2023
20
66
The brain circuitry that is disrupted in Alzheimer's disease appears to influence memory through a type of brain wave known as theta oscillation, a team led by UT Southwestern Medical Center researchers report. The findings, ...
Oct 5, 2023
0
42
A team led by researchers from Mass General Brigham reports promising results for a monoclonal antibody that takes aim at a new target for Alzheimer's disease.
Oct 4, 2023
0
1
